DashboardAll companies
Run this on your own research
Consumer Defensive · Household & Personal Products

Kenvue Inc.

KVUENYSE$19.57−$0.31 (−1.56%)Pre-market

Price Chart

Daily

Key facts

Market Cap
$37.57B
P/E
25.5x
P/B
3.49x
ROE
14.4%

Kenvue Inc.

Consumer Defensive · Household & Personal Products · FY 2025

Kenvue Inc. is a consumer healthcare and pharmaceutical company. It focuses on delivering a range of health-centric products, spanning hygiene, pain relief, and other wellness categories. With deep-rooted expertise in pharmaceuticals, Kenvue Inc. targets the health and wellness needs of individuals, providing both prescription and over-the-counter solutions. The company has established itself as a vital entity in the consumer health sector, significantly impacting community health standards and individual lives. Positioned in the pharmaceutical industry, Kenvue Inc. collaborates with healthcare providers to enhance its product reach and efficacy. Its broad portfolio includes well-known brands and formulations that are trusted globally by consumers seeking reliable health solutions. As a player in this sector, Kenvue Inc. contributes to the enhancement of public health, highlighting its prominence in both domestic and international markets.

CEO
Mr. Thibaut Mongon
Employees
22,000
Website
kenvue.com

Company Statistics

Valuation

P/E
25.5x
P/B
3.49x
P/S
2.48x
EV/EBITDA
13.5x
P/FCF
21.8x

Margins

Gross
58.1%
EBITDA
22.0%
Operating
18.0%
Pre-Tax
13.2%
Net
9.7%

Returns

ROA
5.6%
ROE
14.4%
ROIC
9.2%

Growth (CAGR)

Rev 3Yr
0.4%
Rev 5Yr
0.9%
Op Inc 3Yr
0.5%
Net Inc 3Yr
−10.7%

Financial Health

Cash & Cash Equivalents
$1.06B
Net Debt
$15.25B
Debt/Equity
151.5%
Interest Cov
—

Profile

Revenue
$15.12B
Shares Out
—
Public markets · Korea, US, Japanalpha-lenz.com · Core by Treasurer
Kenvue Inc. (KVUE) Stock Forecast 2026 $19.57 — Price, Financials & Analyst Targets | AlphaLenz